The National Institute of Genomic Medicine (INMEGEN) was

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "The National Institute of Genomic Medicine (INMEGEN) was"

Transcription

1

2 Genome is the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual.

3 What is Genomics? The study of the complete genetic material of an organism. In other words, it is the study of genomes. Genomics should not be confused with genetics, which is the study of single genes and their potential effects. Genomics refers to all of the genetic material of an organism, that is, determining the entire sequence of DNA, including all genes but also non-coding regions.

4 Leader in Genomic Medicine in Latin America The National Institute of Genomic Medicine (INMEGEN) was established in 2004 by the Promotional Consortium of the National Institute of Genomic Medicine. The consortium, created in 2001, was comprised by the National Autonomous University of Mexico, the National Council for Science and Technology, the Ministry of Health and the Mexican Health Foundation. Today, INMEGEN is the national leader in genomic research for medical applications seeking to improve health in Mexico. Its main objectives are: developing scientific research projects with cutting edge technology, training human resources of excellence; and generating genomic innovations and applications to improve health care in compliance with universal ethical principles and respect for human rights. 2

5 Genome Genome is the entire genetic information of any living organism. This information is found in the chromosomes of an organism s cells and is composed of deoxyribonucleic acid (DNA). This contains the hereditary units, called genes, which are responsible for encoding the characteristics of cells and organisms. Genomics Genomics is the study of genes and their biologicial function. It aims at understanding gene structure, gene expression and interpretation of gene-gene interaction. Genomics has revolutionized the Biological Sciences of the 21st century. Genomic Medicine Is the application of genome discoveries to human health and disease. Its main goal is to translate this knowledge into clinical and preventive medicine. Genomics, which was born out of the deciphering of the human genome, is applied to health in what is known as Genomic Medicine. What is Genomic Medicine? Medical practice based on genomic knowledge aimed to produce a more predictive, preventive, participative and personalized medicine. This new branch of medicine aims at understanding quantitatively and qualitatively the genomic, transcriptomic, metabolomic and proteomic contributions to human disease and their relationship to environment. 3

6 Leader in Genomic Medicine in Latin America What is INMEGEN? The National Institute of Genomic Medicine (INMEGEN) is a National Health Institute, leader in genomic research applied to improve health in Mexico. Why is Genomic Medicine important? Human genome variation can be associated to health and disease. The identification of such changes is fundamental to understand, to treat and also to be able to prevent common diseases such as diabetes, obesity, hypertension or cancer. Genomic medicine studies human susceptibility to disease and treatment. Genomic medicine is also closely related to other genomic sciences. Nutrigenomics for example, identifies the effect of diet on gene expression, with the purpose of designing diets based on a specific population genetic profile. Another example of population specific research is Pharmacogenomics that aims at studying drugs and their effect on humans at a molecular level. This research, will soon allow us to have, not only target specific drugs that are effective, but also with minimum side effects. 4

7 The primary role of INMEGEN is the development of research on Genomic Medicine in Mexico. Structure of INMEGEN INMEGEN is integrated by four main areas: Research, Education and Outreach, Technological Development and Entailment and Institutional Development; each with strategic objectives that, as a whole, allow INMEGEN to maintain an undisputed leadership in Mexico. Current fundamental challenges are: 1. The generation of knowledge 2. Education 3. Strategic alliances that integrate the healthcare system in México 4. Access to cutting-edge technology 5. Innovation promotion 6. Open communication with society We promote and implement education programs specialized in Genomic Medicine and all its related sciences. Research Collaboration with clinicians facilitates the development of research projects that will provide the base for future medical practice in Mexico. Understanding the population structure and the epidemiologic characteristics is fundamental for research in Genomic Medicine. Research areas are influenced by worldwide scientific development and available human resources. Lines of Research Genomics of metabolic diseases Oncogenomics Functional genomics of cancer Nutrigenetics and nutrigenomics Genomics of autoimmune and atopic diseases Genomics of cardiovascular disease Proteomics and protein structure Molecular bases of chronic liver diseases Pharmacogenomics Population genomics Ethical, legal and social implications of genomics Computational genomics and expression analysis Genomics of bone metabolism Genomics of cellular response to oxidative stress Genomics and infectious diseases Epigenomics Genomics of premature delivery Genomics of psychiatric and neurological disease 5

8 Leader in Genomic Medicine in Latin America INMEGEN has nurtured a comprehensive education program containing a portfolio of activities directed toward teaching genome medicine at all levels. The Office of Education has taken the next step to get involved with the Institute s commitment to excellence in science, technology and academic training. Education and Outreach This area is devoted to highly specialized training in Genomic Medicine. It offers pre and post graduate courses, academic exchange, continuing education programs and online courses. It is responsible for diseminating scientific information to the Mexican community through the Institute s web site and other digital media. It also coordinates and regulates INMEGEN s specialized digital library. We promote and implement education programs specialized in Genomic Medicine, thus contributing to train professionals capable of assimilating and applying this new knowledge. 6

9 Technological Development Genomic research is characterized by the management and analysis of the massive amounts of data generated by cuttingedge genome technologies. Therefore, there is a constant demand for best practices involving services in highperformance computing, networking, and storage. The sustainability and scalability of information technology (IT) infrastructure are vital to support INMEGEN s science research and its translation to genomic medicine. For the first time in Latin America, products and equipment from leading companies around the world are put together into four High Technology Units at INMEGEN. These offer researchers a broad range of options for genome analysis and high throughput molecular profiling technologies such as Next-Generation Sequencing (NGS). INMEGEN is continuously adapting to increasingly complex research with state of the art technology. The well established and broad training program provides its trainees with advances in genomic innovations in compliance with ethical principles and respect for human rights. By using genomic information we can select the optimal therapeutic strategy for each individual within a specific population. We innovate molecular diagnostics for the Mexican population. 7

10 Leader in Genomic Medicine in Latin America We establish mechanisms that assure compliance with an ethical, legal and social framework within the realm of the development of Genomic Medicine. Entailment and Institutional Development Genomic medicine plays a central role in current healthcare. It has become an important part of diagnosis, prognosis, and treatment in clinical practice. It is therefore essential to include new discoveries as they develop in education and medical practice. INMEGEN maintains strategic alliances with other public and private institutes of health in Mexico and around the world. People at INMEGEN foster an innovative environment fundamental for the generation of services and products that will serve public health. Projects at INMEGEN follow strategic planning, establishing and formalizing legal actions for all of the institute s activities. Services INMEGEN is the Genomic Medicine reference center in Mexico. It offers a variety of services not only to the healthcare sector but also to academic and other non-academic organizations. Services include molecular diagnosis such as paternity tests, pharmacogenomic tests and monitor hematopoietic cell transplant, to mention just a few. Genome research technology services include gene expression, genotyping, next generation sequencing, protein identification, histology and microscopy services. A variety of other projects in the areas of nutrigenomics, pharmacogenomics, cytogenetics and epigenetics can also be proposed. 8

11 Healthcare and wellness decisions will soon include a genomic component. INMEGEN has taken the first steps leading the analysis of genomic diversity of the Mexican population. This research will be translated into medical applications to improve healthcare in Mexico with an important impact on costs for public health. INMEGEN offers continuing and online education, scientific advice and management consulting for technological development and innovation. In order to support research, INMEGEN provides specialized bibliographic services through its digital library. Learn more about INMEGEN and its services at 9

12 Leader in Genomic Medicine in Latin America The library and e-library at INMEGEN aim at disseminating reliable information about discoveries, trends and advances in Genomic Medicine to the scientific community. Our website is designed to provide insights of INMEGEN s research and education to the society. 10

13 Contact Us General Director phone: +52 (55) Ext Research phone: +52 (55) Ext Education Programs and Outreach phone: +52 (55) Ext Entailment and Institutional Development phone: +52 (55) Ext Digital Library phone: +52 (55) Social Communication and Press phone: +52 (55) Ext Courses phone: +52 (55) Ext Internships phone: +52 (55) Ext

14 Leader in Genomic Medicine in Latin America Do you have a smartphone? Scan our QR code and follow us! Facebook Twitter #!/INMEGEN Vimeo Scientific Publications of INMEGEN YouTube Library 12

15

16

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri)

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern

More information

How Can Institutions Foster OMICS Research While Protecting Patients?

How Can Institutions Foster OMICS Research While Protecting Patients? IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice

More information

The HEE Genomics Programme

The HEE Genomics Programme The HEE Genomics Programme Genomics Advisory Board Chaired by Ian Cumming Membership from all relevant stakeholders PHE and PHG Genomics England NHSE Patient and public Royal Colleges Educational leaders,

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE DEFINITIONS FOR GENOMIC BIOMARKERS, PHARMACOGENOMICS,

More information

European registered Clinical Laboratory Geneticist (ErCLG) Core curriculum

European registered Clinical Laboratory Geneticist (ErCLG) Core curriculum (February 2015; updated from paper issued by the European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists, published in February 2012) Speciality Profile

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association 6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising

More information

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research

More information

TRACKS GENETIC EPIDEMIOLOGY

TRACKS GENETIC EPIDEMIOLOGY Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

BIOMEDICAL SCIENCE: A COURSE THAT COUNTS

BIOMEDICAL SCIENCE: A COURSE THAT COUNTS BIOMEDICAL SCIENCE: A COURSE THAT COUNTS Department of Pharmacy, Health and Well-being Why study Biomedical at Sunderland? By studying Biomedical at Sunderland, you are choosing to put your future career

More information

School of Nursing. Presented by Yvette Conley, PhD

School of Nursing. Presented by Yvette Conley, PhD Presented by Yvette Conley, PhD What we will cover during this webcast: Briefly discuss the approaches introduced in the paper: Genome Sequencing Genome Wide Association Studies Epigenomics Gene Expression

More information

Big Data in Healthcare. Dr. Refael Barkan, M.D. Ph.D. Head of RDE at HIT Bar-Ilan University, May 2016

Big Data in Healthcare. Dr. Refael Barkan, M.D. Ph.D. Head of RDE at HIT Bar-Ilan University, May 2016 Big Data in Healthcare Dr. Refael Barkan, M.D. Ph.D. Head of RDE at HIT Bar-Ilan University, May 2016 What is Big Data? Quite nebulous, in the same way that the term cloud covers diverse technologies To

More information

Genetic diagnostics the gateway to personalized medicine

Genetic diagnostics the gateway to personalized medicine Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed

More information

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort

More information

Clinical Research Infrastructure

Clinical Research Infrastructure Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice

More information

REGULATIONS FOR THE DEGREE OF MASTER OF RESEARCH IN MEDICINE (MRes[Med])

REGULATIONS FOR THE DEGREE OF MASTER OF RESEARCH IN MEDICINE (MRes[Med]) REGULATIONS FOR THE DEGREE OF MASTER OF RESEARCH IN MEDICINE (MRes[Med]) (See also General Regulations) Any publications based on work approved for a higher degree should contain a reference to the effect

More information

European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute

European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute Justin Paschall Team Leader Genetic Variation / EGA ! European Genome-phenome

More information

Graduate Program Objective #1 Course Objectives

Graduate Program Objective #1 Course Objectives 1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.

More information

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health. HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE Field Name Description Translational Research Mortality Analysis Join University-Conselleria Unit for Translational Research in the health

More information

DISCOVERY WITHOUT BOUNDARIES

DISCOVERY WITHOUT BOUNDARIES DISCOVERY WITHOUT BOUNDARIES Strategic Plan Summary 2013 The Francis Crick Institute is an exciting project to create a world-leading multi-disciplinary biomedical research institute at the heart of London.

More information

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

Food Sci+Human Nutrition-FSHN (FSHN)

Food Sci+Human Nutrition-FSHN (FSHN) Colorado State University 1 Food Sci+Human Nutrition-FSHN (FSHN) Courses FSHN 125 Food and Nutrition in Health Credits: Nutritional quality and safety of food related to human health. Grade Modes: S/U

More information

Preparing the scenario for the use of patient s genome sequences in clinic. Joaquín Dopazo

Preparing the scenario for the use of patient s genome sequences in clinic. Joaquín Dopazo Preparing the scenario for the use of patient s genome sequences in clinic Joaquín Dopazo Computational Medicine Institute, Centro de Investigación Príncipe Felipe (CIPF), Functional Genomics Node, (INB),

More information

Draft NIEHS Strategic Plan. Mission, Vision, Strategic Pillars, Strategic Goals. Draft Mission Statement

Draft NIEHS Strategic Plan. Mission, Vision, Strategic Pillars, Strategic Goals. Draft Mission Statement Draft NIEHS Strategic Plan Mission, Vision, Strategic Pillars, Strategic Goals Draft Mission Statement The mission of the National Institute of Environmental Health Sciences is to discover how the environment

More information

In recent years the number of DNA genetic tests that you can

In recent years the number of DNA genetic tests that you can Inside How accurate are the tests? 2 How useful are the tests? 2 What can Direct-to-Consumer DNA genetic tests tell me? 2 What happens to my personal information? 3 What protections are there in Australia?

More information

Rare disease research in FP7, Outlook in Horizon 2020, IRDiRC

Rare disease research in FP7, Outlook in Horizon 2020, IRDiRC Rare disease research in FP7, Outlook in Horizon 2020, IRDiRC Dr. Iiro Eerola Scientific Project Officer Unit for Personalised Medicine Directorate F Health DG Research and European Commission iiro.eerola@ec.europa.eu

More information

ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH

ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH 22 nd Annual Health Care Systems Research Network (HCSRN) Conference (formerly HMO Research Network Conference) ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH Hosted by: Marshfield Clinic

More information

European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists

European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists Clinical Laboratory Genetics as an EU-recognized specialist profession Aims and objectives for

More information

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program

More information

Phenomenome Discoveries. Cutting Edge Disease Prevention Research 1

Phenomenome Discoveries. Cutting Edge Disease Prevention Research 1 Cutting Edge Disease Prevention Research 1 Phenomenome Discoveries Inc. Phenomenome Discoveries Inc (PDI) is a life science company focused on the discovery and development of simple blood chemistry tests

More information

Lucia Migliore. Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice

Lucia Migliore. Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice Lucia Migliore Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice Dipartimento di Ricerca Traslazionale e Nuove Tecnologie in Medicina

More information

Cancer Genomics: What Does It Mean for You?

Cancer Genomics: What Does It Mean for You? Cancer Genomics: What Does It Mean for You? The Connection Between Cancer and DNA One person dies from cancer each minute in the United States. That s 1,500 deaths each day. As the population ages, this

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES MAY 2014. May 2014 ABA 298 1 Technologies, Products & Services

More information

laboratory of genetic diagnostic and preventive medicine_ Total Health Care _Personalised Report and Advice on Genetic Tests _

laboratory of genetic diagnostic and preventive medicine_ Total Health Care _Personalised Report and Advice on Genetic Tests _ laboratory of genetic diagnostic and preventive medicine_ Total Health Care _Personalised Report and Advice on Genetic Tests _ Introduction_Personalised genetic tests for your health, body weight, nutrition

More information

1. WHY ARE ELECTRONIC MEDICAL RECORDS IMPORTANT FOR PERSONALIZED MEDICINE?

1. WHY ARE ELECTRONIC MEDICAL RECORDS IMPORTANT FOR PERSONALIZED MEDICINE? THE ELECTRONIC MEDICAL RECORD: A CRITICAL ISSUE IN PERSONALIZED MEDICINE 1. WHY ARE ELECTRONIC MEDICAL RECORDS IMPORTANT FOR PERSONALIZED MEDICINE? As initially configured, electronic medical records (EMRs)

More information

PERSONALIZED MEDICINE: Tailoring Health Care for the Information Age

PERSONALIZED MEDICINE: Tailoring Health Care for the Information Age PERSONALIZED MEDICINE: Tailoring Health Care for the Information Age Bob West, Ph.D. SUNY Upstate Medical University @westr JAMA, 2008 #HANYSSM The OLD and the NEW #HANYSSM The OLD #HANYSSM 21 st Century

More information

Master of Science in Biochemistry (Molecular Medicine Option).

Master of Science in Biochemistry (Molecular Medicine Option). Master of Science in Biochemistry (Molecular Medicine Option). Molecular medicine is a specialized area of medicine. Its main thrust is to understand the molecular and cellular basis of disease. Understanding

More information

Overview of Enabling Technologies in the Life Sciences. Professor Andrew Pitt, Aston University, Birmingham, UK

Overview of Enabling Technologies in the Life Sciences. Professor Andrew Pitt, Aston University, Birmingham, UK Overview of Enabling Technologies in the Life Sciences Professor Andrew Pitt, Aston University, Birmingham, UK Overview of Enabling Technologies in the Life Sciences Convergence Professor Andrew Pitt,

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

The ASGCT invites you to submit your research to the largest scientific conference of its kind!

The ASGCT invites you to submit your research to the largest scientific conference of its kind! American Society of Gene & Cell Therapy A N N U A L M E E T I N G th May 16-19 2 0 1 2 Philadelphia PA USA The ASGCT invites you to submit your research to the largest scientific conference of its kind!

More information

SAP HANA Enabling Genome Analysis

SAP HANA Enabling Genome Analysis SAP HANA Enabling Genome Analysis Joanna L. Kelley, PhD Postdoctoral Scholar, Stanford University Enakshi Singh, MSc HANA Product Management, SAP Labs LLC Outline Use cases Genomics review Challenges in

More information

Scientists don t yet fully

Scientists don t yet fully Alzheimer s Disease Genetics FACT SHEET Scientists don t yet fully understand what causes Alzheimer s disease. However, the more they learn about this devastating disease, the more they realize that genes*

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015

#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015 Genomics, Precision Medicine and the EHR Making Genomics part of everyday practice Andrew Ury, M.D. CEO and founder, ActX, Inc. June 17, 2015 DISCLAIMER: The views and opinions expressed in this presentation

More information

Human Mendelian Disorders. Genetic Technology. What is Genetics? Genes are DNA 9/3/2008. Multifactorial Disorders

Human Mendelian Disorders. Genetic Technology. What is Genetics? Genes are DNA 9/3/2008. Multifactorial Disorders Human genetics: Why? Human Genetics Introduction Determine genotypic basis of variant phenotypes to facilitate: Understanding biological basis of human genetic diversity Prenatal diagnosis Predictive testing

More information

Genetic Tests for Health Purposes

Genetic Tests for Health Purposes Genetic Tests for Health Purposes Genetic Tests for Health Purposes We have all inherited a unique combination of genes from our parents. This original constitution and the influence of various environmental

More information

MOLECULAR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

MOLECULAR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS MOLECULAR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS R. M. Weinshilboum, M.D., Program Director L. Wang, M.D., Ph.D., Program Co-Director D. C. Mays, Ph.D., Associate Program Director Ph.D. Degree Course

More information

Next Generation Sequencing Informatics Markets

Next Generation Sequencing Informatics Markets Next Generation Sequencing Informatics Markets Greg Caressi SVP Healthcare & Life Sciences November, 2014 Personalization, Communication, Decentralization, Collaboration From... One Size Fits All APPROACH...To

More information

Resumen Curricular de los Profesores. Jesse Boehm

Resumen Curricular de los Profesores. Jesse Boehm Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub

More information

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16 Course Director: Dr. Barry Grant (DCM&B, bjgrant@med.umich.edu) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems

More information

Special Report. Ruxandra Draghia-Akli

Special Report. Ruxandra Draghia-Akli For reprint orders, please contact: reprints@futuremedicine.com Enabling personalized medicine in Europe: a look at the European Commission s funding activities in the field of personalized medicine research

More information

Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences

Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences Personalized Medicine: Humanity s Ultimate Big Data Challenge Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences 2012 Oracle Corporation Proprietary and Confidential 2 3 Humanity

More information

If you were diagnosed with cancer today, what would your chances of survival be?

If you were diagnosed with cancer today, what would your chances of survival be? Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However

More information

The Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins

The Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins The Future of the Electronic Health Record Gerry Higgins, Ph.D., Johns Hopkins Topics to be covered Near Term Opportunities: Commercial, Usability, Unification of different applications. OMICS : The patient

More information

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...

More information

Elective Options for MS in Clinical and Translational Sciences Program

Elective Options for MS in Clinical and Translational Sciences Program Elective Options for MS in Clinical and Translational Sciences Program NOTE: ALL ELECTIVES MUST BE GRADUATE LEVEL COURSES AND APPROVED BY A MS CTS PROGRAM DIRECTOR IN ORDER TO RECEIVE CREDIT TOWARDS MCTS

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider Daniel Masys, M.D. Affiliate Professor Biomedical and Health Informatics University of Washington, Seattle

More information

EMBL-EBI's training programme Improving accessibility to industrial users. Cath Brooksbank PhD Head of Training

EMBL-EBI's training programme Improving accessibility to industrial users. Cath Brooksbank PhD Head of Training EMBL-EBI's training programme Improving accessibility to industrial users Cath Brooksbank PhD Head of Training cath@ebi.ac.uk Acknowledgements With special thanks to Training: a core part of EMBL-EBI s

More information

2016 Molecular Pathology Series (ASCPi)

2016 Molecular Pathology Series (ASCPi) Lecture Hall, Federation of Medical Societies of, 4th Floor, Duke of Windsor Social Service Building, 15 Hennessy Road, Wanchai, 12 Apr (TUE) Molecular Science I 1. Nucleic Acid Chemistry 2. Structure

More information

REINVENTING THE SCIENCE OF DRUG DISCOVERY

REINVENTING THE SCIENCE OF DRUG DISCOVERY REINVENTING THE SCIENCE OF DRUG DISCOVERY The science of pharmacology and the business of drug discovery are ready for reinvention. Using big data and advanced analytics to combat disease Over the past

More information

Integration of Genetic and Familial Data into. Electronic Medical Records and Healthcare Processes

Integration of Genetic and Familial Data into. Electronic Medical Records and Healthcare Processes Integration of Genetic and Familial Data into Electronic Medical Records and Healthcare Processes By Thomas Kmiecik and Dale Sanders February 2, 2009 Introduction Although our health is certainly impacted

More information

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies

More information

ATIP Avenir Program 2014. Applicant s guide

ATIP Avenir Program 2014. Applicant s guide ATIP Avenir Program 2014 Applicant s guide Important dates: - November 29 th 2013: deadline for the online submission, the mailing of the hard copy of the scientific project, and the letters of recommendation

More information

Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes

Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning

More information

The Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative

The Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative The Human Genome Project From genome to health From human genome to other genomes and to gene function Structural Genomics initiative June 2000 What is the Human Genome Project? U.S. govt. project coordinated

More information

30 Nature Methods 31 Nature Microbiology 32 Nature Nanotechnology 33 Nature Neuroscience 34 Nature Photonics 35 Nature Physics 36 Nature Plants 37

30 Nature Methods 31 Nature Microbiology 32 Nature Nanotechnology 33 Nature Neuroscience 34 Nature Photonics 35 Nature Physics 36 Nature Plants 37 Nature titles Journal 1 Nature 2 Nature Reviews Cancer 3 Nature Reviews Cardiology 4 Nature Reviews Clinical Oncology 5 Nature Reviews Disease Primers 6 Nature Reviews Drug Discovery 7 Nature Reviews Endocrinology

More information

Prognosis for Healthcare: The Future of Medicine

Prognosis for Healthcare: The Future of Medicine Prognosis for Healthcare: The Future of Medicine Bruce M. Cohen, M.D., Ph.D. Director, Frazier Research Institute, McLean Hospital President and Psychiatrist in Chief Emeritus, McLean Hospital Robertson-Steele

More information

Tokyo Medical and Dental University

Tokyo Medical and Dental University Tokyo Medical and Dental University Biomedical Science and Technology Track Disease Prevention Leadership Program (5-year Master s and Doctoral Program) Admission Guide 2015 For Self-Supporting International

More information

The 100,000 genomes project

The 100,000 genomes project The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000

More information

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry The Master Degree in Medical Laboratory Sciences /Clinical Biochemistry, is awarded by the Faculty of Graduate Studies

More information

GENETICS COURSES AT SCHOOLS OF PUBLIC HEALTH WEB SEARCH - 38 SCHOOLS SACGHS - 11/20/07

GENETICS COURSES AT SCHOOLS OF PUBLIC HEALTH WEB SEARCH - 38 SCHOOLS SACGHS - 11/20/07 Number of Biostatistically, Epidemiologically, or Biologically based Courses Number of Health Management/Law based classes School Courses Centers Other Boston U BS858 Statistical 3 2 BS860 Statistical

More information

Attacking the Biobank Bottleneck

Attacking the Biobank Bottleneck Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand

More information

Biotherapeutic Medicines

Biotherapeutic Medicines International Federation of Pharmaceutical Manufacturers & Associations Biotherapeutic Medicines Grasping the New Generation of Treatments Biotherapeutic medicines are an integral and valuable part of

More information

FROM INSIGHT TO OUTCOME DISEASE RESEARCH AT AGILENT

FROM INSIGHT TO OUTCOME DISEASE RESEARCH AT AGILENT FROM INSIGHT TO OUTCOME DISEASE RESEARCH AT AGILENT UNDERSTANDING COMPLEX DISEASE PROCESSES Complex diseases, including cancer, cardiovascular disease, diabetes, and Alzheimer s disease, are caused by

More information

Dr Alexander Henzing

Dr Alexander Henzing Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander

More information

BSc Biomedical Science Degree

BSc Biomedical Science Degree Fullscreen Next page BSc Biomedical Science Degree Overview...2 BSc Biomedical Science...3 BSc Biomedical Science Pathway...4 BSc Biomedical Science Biochemistry Pathway...5 BSc Biomedical Science Pathway...6

More information

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF ALLIED HEALTH SCIENCES FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes

More information

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources 1 of 8 11/7/2004 11:00 AM National Center for Biotechnology Information About NCBI NCBI at a Glance A Science Primer Human Genome Resources Model Organisms Guide Outreach and Education Databases and Tools

More information

Pharmacology skills for drug discovery. Why is pharmacology important?

Pharmacology skills for drug discovery. Why is pharmacology important? skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th

More information

Griffith University - Case for Support. Mesothelioma Research Program

Griffith University - Case for Support. Mesothelioma Research Program Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health

More information

The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015

The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015 Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

Online Direct To Consumer Testing: A Public Health Perspective

Online Direct To Consumer Testing: A Public Health Perspective Online Direct To Consumer Testing: A Public Health Perspective GPS GE 3 LS SERIES Ottawa, June 29, 2010 Mohamed Karmali Director General Office of Biotechnology, Genomics and Population Health Public Health

More information

MCB 4934: Introduction to Genetics and Genomics in Health Care Section 125D Fall 2012 2 Credits

MCB 4934: Introduction to Genetics and Genomics in Health Care Section 125D Fall 2012 2 Credits MCB 4934: Introduction to Genetics and Genomics in Health Care Section 125D Fall 2012 2 Credits Instructor Dr. Jennifer Drew Microbiology & Cell Science jdrew@ulf.edu Skype username: jennifercdrew I am

More information

A polynucleotide consisting of the nucleotide sequence of SEQ ID NO:2.

A polynucleotide consisting of the nucleotide sequence of SEQ ID NO:2. Case A A polynucleotide consisting of the nucleotide sequence of SEQ ID NO:1 nucleotide sequence of SEQ ID NO:1 is one of the sequences which were analyzed using an automated DNA sequencer The sequences

More information

Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors

Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors FISH (fluorescence in situ hybridization) assays and many probes that

More information

TECHNOLOGY PATENTS IN THE (CONTINUED)... 16

TECHNOLOGY PATENTS IN THE (CONTINUED)... 16 CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY AND INFORMATION SOURCES... 2 INTENDED AUDIENCE... 2 ANALYST CREDENTIALS...

More information

Graduate Certificate Pre-Med Program Course Descriptions For Year 2015-2016 FALL

Graduate Certificate Pre-Med Program Course Descriptions For Year 2015-2016 FALL Graduate Certificate Pre-Med Program Course Descriptions For Year 2015-2016 FALL COURSE TITLE: BIOCHEMISTRY COURSE NUMBER: 5104 This course emphasizes biochemical compounds, processes and systems, designed

More information

> Semantic Web Use Cases and Case Studies

> Semantic Web Use Cases and Case Studies > Semantic Web Use Cases and Case Studies Case Study: Applied Semantic Knowledgebase for Detection of Patients at Risk of Organ Failure through Immune Rejection Robert Stanley 1, Bruce McManus 2, Raymond

More information

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology

More information

Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!

Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!! Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l

More information

Nature of Genetic Material. Nature of Genetic Material

Nature of Genetic Material. Nature of Genetic Material Core Category Nature of Genetic Material Nature of Genetic Material Core Concepts in Genetics (in bold)/example Learning Objectives How is DNA organized? Describe the types of DNA regions that do not encode

More information

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before

More information

Ethical and Public Health Implications of Genomic and Personalised Medicine. Dr Ingrid Slade

Ethical and Public Health Implications of Genomic and Personalised Medicine. Dr Ingrid Slade Ethical and Public Health Implications of Genomic and Personalised Medicine Dr Ingrid Slade Ethical and Public Health Implications of Genomic and Personalised Medicine What is personalised medicine and

More information

Pharmacogenomics: an important step in the quest for biomarkers of drug response

Pharmacogenomics: an important step in the quest for biomarkers of drug response PHARMACOGENOMICS Development drugs/biologicals against completely new drug targets Pharmacogenomics: an important step in the quest for biomarkers of drug response Studying genetic variants as effect modifier

More information